This company is engaged in manufacturing of pharmaceutical_products. It conducts_business_from its_registered_head office_located in LOCATION_LOCATION_LOCATION_LOCATION COUNTRY COUNTRY COUNTRY. The company was_founded in DATE. The company specialises in providing ORGANIZATION ORGANIZATION ORGANIZATION ORGANIZATION ORGANIZATION (CDMO) services for advanced_biopharmaceuticals,_particularly in the field of cell_gene_therapy. The company 's_product_portfolio includes_cell_therapies, genetically_modified_cell_therapies, genetically_modified_stem_cell therapies,_exosome_therapies, and stem_cell_treatments. It offers a range of services, such_as ORGANIZATION manufacturing, quality services, and regulatory_response_support, covering_various_stages of development from clinical to commercial_phases._Additionally, the company focuses_on technology_development, including scale - up technologies for adherent_cell_cultures and 2D_automated_manufacturing,_demonstrating expertise in the biopharmaceutical_industry.